Divis Lab Q4 PAT rises 29% YoY to Rs 502 cr : vimarsana.com

Read more about Divis Lab Q4 PAT rises 29% YoY to Rs 502 cr on Business Standard. On a consolidated basis, Divi's Laboratories posted a 29.3% rise in net profit to Rs 502.02 crore in Q4 FY21 compared with Rs 388.23 crore in Q4 FY20.

Related Keywords

, Capital Market , Pharmaceuticals Nec , Divis Laboratories , S 1 , Pharmaceuticals Ingredients , Major , Apis , C , மூலதனம் சந்தை , மருந்துகள் கழுத்து , கள் , பீஸ் ,